Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?
This Drug Could Outsell Medical Marijuana
Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.
Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
Bristol-Myers Squibb's Opdivo and Merck's Keytruda are sought after drugs for combination cancer treatments.